SCHEMBL16403447

SCHEMBL16403447

CNS(=O)(=O)C(OC(N)=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
PKM P14618 1/20 0.40
KMT2A Q03164 4/20 0.40
BCAT2 O15382 1/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GMNN O75496 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
PMP22 Q01453 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX5 P09917 1/20 0.37
CTSD P07339 1/20 0.36
SRC P12931 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18051140 0.79 ALDH1A1 (0.41) NPSR1CYP2D6PKMKMT2AALDH1A1
SCHEMBL19183147 0.75 SRC (0.47) NPSR1CYP2D6KMT2ABCAT2ALDH1A1
SCHEMBL7088315 0.74 LMNA (0.34) KMT2AALDH1A1LMNA
SCHEMBL8661391 0.71 ALDH1A1 (0.43) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL10520492 0.70 HCAR2 (0.50) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL5931089 0.70 L3MBTL1 (0.39) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL27820414 0.70 HCAR2 (0.58) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL6478149 0.70 HCAR2 (0.58) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL264866 0.70 HCAR2 (0.58) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL5956415 0.70 HCAR2 (0.58) NPSR1SMN1; SMN2CYP1A2CYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3003314-A2 NOVEL COMPOUNDS AND USES THEREOF Kala Pharmaceuticals, Inc. (US) 2016-04-13 EP disclosed
WO-2014197313-A2 NOVEL COMPOUNDS AND USES THEREOF KALA PHARMACEUTICALS, INC. (US) 2014-12-11 WO disclosed